Life-threatening dermatoses due to metabolic and endocrine disorders

Area of Science:

• Cardiovascular Medicine
• Endocrinology
• Dermatology

Background:

• Atherosclerosis is a leading cause of death and disability globally.
• It is closely associated with metabolic conditions like lipid metabolism disorders, diabetes mellitus (DM), and insulin resistance.
• Less common but critical are thyroid function and porphyrin metabolism disorders.

Purpose of the Study:

• To highlight the connection between systemic diseases and dermatological manifestations.
• To emphasize the role of skin conditions in the early diagnosis of underlying metabolic and endocrine disorders.
• To advocate for integrated diagnostic approaches for cardiovascular risk reduction.

Main Methods:

• Review of existing literature on atherosclerosis, metabolic disorders, and associated dermatoses.
• Analysis of clinical case studies linking specific skin conditions to underlying diseases.
• Correlation of dermatological signs with biochemical and clinical markers of disease.

Main Results:

• Characteristic skin findings are consistently observed in patients with lipid metabolism disorders, DM, and insulin resistance.
• Thyroid dysfunction and porphyrin metabolism disorders also present with distinct dermatoses.
• Early identification of these dermatoses can signal the presence of serious systemic illness.

Conclusions:

• Dermatoses serve as valuable clinical indicators for early detection of atherosclerosis-related conditions.
• Integrating dermatological assessment into routine screening can improve the diagnosis of metabolic and endocrine diseases.
• Prompt intervention based on dermatological findings can mitigate cardiovascular morbidity and mortality.